These monogenic non-syndromic obesity disorders are mainly driven by molecular alterations in hypothalamic pathways involved in appetite regulation and weight regulation through the leptin-melanocortin pathway. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.